Barclays’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Buy |
3,476
+168
| +5% | +$1.16K | ﹤0.01% | 4063 |
|
|
2025
Q1 | $28K | Buy |
3,308
+696
| +27% | +$5.89K | ﹤0.01% | 4009 |
|
|
2024
Q4 | $37K | Buy |
2,612
+2,345
| +878% | +$33.2K | ﹤0.01% | 4012 |
|
|
2024
Q3 | $6K | Buy |
267
+183
| +218% | +$4.11K | ﹤0.01% | 4172 |
|
|
2024
Q2 | $2K | Hold |
84
| – | – | ﹤0.01% | 4085 |
|
|
2024
Q1 | $2K | Sell |
84
-14,948
| -99% | -$356K | ﹤0.01% | 4094 |
|
|
2023
Q4 | $272K | Buy |
15,032
+14,864
| +8,848% | +$269K | ﹤0.01% | 3367 |
|
|
2023
Q3 | $4K | Buy |
168
+84
| +100% | +$2K | ﹤0.01% | 4125 |
|
|
2023
Q2 | $2K | Hold |
84
| – | – | ﹤0.01% | 4151 |
|
|
2023
Q1 | $2K | Buy |
+84
| New | +$2K | ﹤0.01% | 4213 |
|
|
2022
Q2 | – | Sell |
-2,129
| Closed | -$93K | – | 4706 |
|
|
2022
Q1 | $93K | Sell |
2,129
-1,471
| -41% | -$64.3K | ﹤0.01% | 3703 |
|
|
2021
Q4 | $219K | Sell |
3,600
-2,522
| -41% | -$153K | ﹤0.01% | 2802 |
|
|
2021
Q3 | $255K | Buy |
6,122
+1,522
| +33% | +$63.4K | ﹤0.01% | 2872 |
|
|
2021
Q2 | $140K | Sell |
4,600
-15,900
| -78% | -$484K | ﹤0.01% | 3026 |
|
|
2021
Q1 | $612K | Buy |
+20,500
| New | +$612K | ﹤0.01% | 2560 |
|